Phathom Pharma’s Vonoprazan Commercial Preparation Update At Needham Healthcare Conference
At the Needham Healthcare Conference, Phathom Pharmaceuticals Inc (NASDAQ:PHAT) says that licensor Takeda Pharmaceutical Co Ltd (NYSE: TAK) reported Takecab (vonoprazan) Q4 FY21…